Consumers General

MMJ PhytoTech Ltd (ASX:MMJ) Filing Statement Ahead of MediPharm Labs Listing

🕔9/25/2018 1:31:41 PM

MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the filing statement related to the imminent listing, by way of a reverse takeover, of MediPharm Labs, Inc. on the TSX Venture Exchange.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Up Cannabis Signs Agreement with MediPharm Labs

🕔9/25/2018 12:50:10 PM

MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the attached news release confirming that Up Cannabis Inc., a wholly-owned subsidiary of Newstrike Brands Ltd (CVE:HIP), has entered into an agreement with MediPharm Labs Inc. to supply up to 1,200 kilograms of cannabis flower and shake that will be used for the purpose of extraction and the creation of cannabis oil and/or distillate.

Read Full Article

Collaborate Corporation Ltd (ASX:CL8) Despatch of Entitlement Issue Prospectus

🕔9/24/2018 4:17:04 PM

Collaborate Corporation Limited (ASX:CL8) is pleased to confirm the despatch today of the prospectus as lodged with ASIC and ASX on 14 September 2018, including the entitlement and acceptance form, for the partially underwritten non-renounceable entitlement issue of shares to raise approximately $1.16 million before costs.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Annual Report to Shareholders

🕔9/24/2018 9:46:22 AM

MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company's Annual Report to shareholders.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Fire & Flower Proposes to List on the TSX-V

🕔9/20/2018 11:37:40 AM

MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the attached announcement confirming that Fire & Flower Inc. proposes to list on the TSX Venture Exchange by way of a reverse takeover transaction.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Medipharm Labs Interview with Proactive Investors

🕔9/20/2018 11:21:00 AM

MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the interview with Proactive Investors Vancouver given by Pat McCutcheon, President and CEO of MediPharm Labs, Inc., providing a detailed description of their business and revenue model.

Read Full Article

MNF Group Ltd (ASX:MNF) Dividend Reinvestment Plan Price and Participation

🕔9/20/2018 10:41:45 AM

The Board of MNF Group Limited (ASX:MNF) is pleased to advise that the subscription price for the Dividend Reinvestment Plan applicable to the 2018 final dividend is $4.63 per share.

Read Full Article